Use of topical rapamycin in the treatment of superficial lymphatic malformations.

Background: The superficial lymphatic component of vascular malformations poses a significant treatment challenge. It is responsible for the majority of symptoms presented, and to date, there is no consensus regarding treatment.

Objective: To evaluate the effectiveness of topical rapamycin in treating superficial lymphatic malformations (LM).